Detalhe da pesquisa
1.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363833
2.
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.
Blood
; 142(18): 1570-1575, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595284
3.
Human CXCR5+ PD-1+ CD8 T cells in healthy individuals and patients with hematologic malignancies.
Eur J Immunol
; 51(3): 703-713, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098668
4.
The quest for a cure in follicular lymphoma.
Blood
; 143(6): 475-476, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38329775
5.
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy.
Blood
; 134(1): 44-58, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076448
6.
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Haematologica
; 106(4): 1129-1137, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273476
7.
Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant Lymphocytes.
J Immunol
; 203(8): 2100-2109, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511358
8.
Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib.
Blood
; 132(21): 2260-2272, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213872
9.
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Mycoses
; 62(12): 1140-1147, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31520441
10.
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia.
Int J Mol Sci
; 20(17)2019 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484424
11.
How does lenalidomide target the chronic lymphocytic leukemia microenvironment?
Blood
; 124(14): 2184-9, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25161268
12.
CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia.
Blood
; 123(5): 717-24, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24246502
13.
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Blood Cancer J
; 13(1): 130, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658062
14.
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP.
Leukemia
; 36(12): 2853-2862, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241696
15.
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Lancet Haematol
; 9(3): e190-e199, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240075
16.
How to choose first salvage therapy in Hodgkin lymphoma: traditional chemotherapy vs novel agents.
Hematology Am Soc Hematol Educ Program
; 2021(1): 240-246, 2021 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889399
17.
Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837.
Cancers (Basel)
; 13(19)2021 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638518
18.
Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989-2016.
Leukemia
; 35(6): 1683-1695, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046819
19.
No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.
Blood
; 112(3): 840-3, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18519815
20.
Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma.
Cancers (Basel)
; 12(12)2020 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33353234